These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

553 related items for PubMed ID: 17540812

  • 1. Cost-effectiveness analysis of strategies for the surgical management of grade 1 endometrial adenocarcinoma.
    Cohn DE, Huh WK, Fowler JM, Straughn JM.
    Obstet Gynecol; 2007 Jun; 109(6):1388-95. PubMed ID: 17540812
    [Abstract] [Full Text] [Related]

  • 2. Cost-effectiveness analysis of strategies for the surgical management of grade 1 endometrial adenocarcinoma.
    Kwon J, Carey M, Goldie S, Kim J.
    Obstet Gynecol; 2007 Oct; 110(4):933; author reply 933-4. PubMed ID: 17906041
    [No Abstract] [Full Text] [Related]

  • 3. Is selective lymphadenectomy more cost-effective than routine lymphadenectomy in patients with endometrial cancer?
    Clements AE, Tierney BJ, Cohn DE, Straughn JM.
    Gynecol Oncol; 2013 Feb; 128(2):166-70. PubMed ID: 23078763
    [Abstract] [Full Text] [Related]

  • 4. The impact of age on long-term outcome in patients with endometrial cancer treated with postoperative radiation.
    Jolly S, Vargas CE, Kumar T, Weiner SA, Brabbins DS, Chen PY, Floyd W, Martinez AA.
    Gynecol Oncol; 2006 Oct; 103(1):87-93. PubMed ID: 16545441
    [Abstract] [Full Text] [Related]

  • 5. Long-term outcomes of therapeutic pelvic lymphadenectomy for stage I endometrial adenocarcinoma.
    Mohan DS, Samuels MA, Selim MA, Shalodi AD, Ellis RJ, Samuels JR, Yun HJ.
    Gynecol Oncol; 1998 Aug; 70(2):165-71. PubMed ID: 9740684
    [Abstract] [Full Text] [Related]

  • 6. Pelvic lymphadenectomy as alternative to postoperative radiotherapy in high risk early stage endometrial cancer.
    Papanikolaou A, Kalogiannidis I, Goutzioulis M, Misailidou D, Makedos A, Vergote I, Makedos G.
    Arch Gynecol Obstet; 2006 May; 274(2):91-6. PubMed ID: 16518607
    [Abstract] [Full Text] [Related]

  • 7. The long-term survival of women with surgical stage II endometrioid type endometrial cancer.
    Ayhan A, Taskiran C, Celik C, Yuce K.
    Gynecol Oncol; 2004 Apr; 93(1):9-13. PubMed ID: 15047207
    [Abstract] [Full Text] [Related]

  • 8. Conservative management of stage I endometrial carcinoma after surgical staging.
    Straughn JM, Huh WK, Kelly FJ, Leath CA, Kleinberg MJ, Hyde J, Numnum TM, Zhang Y, Soong SJ, Austin JM, Partridge EE, Kilgore LC, Alvarez RD.
    Gynecol Oncol; 2002 Feb; 84(2):194-200. PubMed ID: 11812074
    [Abstract] [Full Text] [Related]

  • 9. Cost-effectiveness of adjuvant radiotherapy in intermediate risk endometrial cancer.
    Rankins NC, Secord AA, Jewell E, Havrilesky LJ, Soper JT, Myers E.
    Gynecol Oncol; 2007 Aug; 106(2):388-93. PubMed ID: 17509672
    [Abstract] [Full Text] [Related]

  • 10. Potential benefit of lymphadenectomy for the treatment of node-negative locally advanced uterine cancers.
    Seago DP, Raman A, Lele S.
    Gynecol Oncol; 2001 Nov; 83(2):282-5. PubMed ID: 11606085
    [Abstract] [Full Text] [Related]

  • 11. Cost-effectiveness analysis of the treatment for intermediate risk endometrial cancer: postoperative brachytherapy vs. observation.
    Fanning J, Hoffman ML, Andrews SJ, Harrah AW, Feldmeier JJ.
    Gynecol Oncol; 2004 Jun; 93(3):632-6. PubMed ID: 15196856
    [Abstract] [Full Text] [Related]

  • 12. Cost effectiveness of a test to detect metastases for endometrial cancer.
    Havrilesky LJ, Maxwell GL, Chan JK, Myers ER.
    Gynecol Oncol; 2009 Mar; 112(3):526-30. PubMed ID: 19100608
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cost-effectiveness of treatment of early stage endometrial cancer.
    Ashih H, Gustilo-Ashby T, Myers ER, Andrews J, Clarke-Pearson DL, Berry D, Berchuck A.
    Gynecol Oncol; 1999 Aug; 74(2):208-16. PubMed ID: 10419733
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. FIGO stage IIIC endometrial carcinoma: prognostic factors and outcomes.
    Hoekstra AV, Kim RJ, Small W, Rademaker AW, Helenowski IB, Singh DK, Schink JC, Lurain JR.
    Gynecol Oncol; 2009 Aug; 114(2):273-8. PubMed ID: 19428094
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Multicenter analysis of recurrence and survival in stage IIIA endometrial cancer.
    Havrilesky LJ, Secord AA, O'Malley DM, Broadwater G, Bae-Jump V, Cohn DE, Gehrig PA.
    Gynecol Oncol; 2009 Aug; 114(2):279-83. PubMed ID: 19446319
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.